Stay updated on Bispecific Antibody MCLA-158 Clinical Trial

Sign up to get notified when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bispecific Antibody MCLA-158 Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s implementation. This appears to be a behind-the-scenes maintenance update rather than a change to the study content shown on the page.
    Difference
    0.0%
    Check dated 2026-09-01T20:52:00.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    An NIH grant/contract identifier was added to the study's identifiers, linking the trial to U.S. NIH funding.
    Difference
    0.0%
    Check dated 2026-08-25T21:29:21.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5 on the page. This appears to be a minor metadata/patch update and does not change study data or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-11T21:48:56.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page adds details about new expansion cohorts and dosing (RP2D of 1500 mg every 2 weeks for single-agent MCLA-158) and outlines planned combination cohorts with pembrolizumab, FOLFIRI, and FOLFOX. It also updates recruitment sites, investigators, and contact information across many locations.
    Difference
    6%
    Check dated 2026-08-04T17:33:51.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page, signaling a minor update to the study details page. No substantive study data or user-visible content appears to be changed.
    Difference
    0.0%
    Check dated 2026-07-28T15:13:57.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    - Page revision updated from v3.6.0 to v3.6.3, indicating a new build/version of the page rather than a change to the study content. This is a metadata-level update visible on the page.
    Difference
    0.0%
    Check dated 2026-06-30T01:07:42.000Z thumbnail image

Stay in the know with updates to Bispecific Antibody MCLA-158 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.